BP-Cx-1

BP-Cx-1 A globular polydentant ligand, is a refined polymer of the benzo-poly-carbonic family. BP-Cx-1 has a number of favorable biochemical and therapeutic properties. BP-Cx-1 is capable …

BP-C1

BP-C1 Is based on a combination of BP-Cx-1 and platinum. It contains approximately 100 times less platinum than ordinary doses of Cisplatin used in chemotherapeutical …

BP-C2

BP-C2 The company’s second product is BP-C2, which is based on BP-Cx-1 combined with molybdenum salts. BP-C2 is in preclinical development as an oral agent …

BP-Cx-1

BP-Cx-1 A globular polydentant ligand, is a refin...

BP-C1

BP-C1 Is based on a combination of BP-Cx-1 and pl...

BP-C2

BP-C2 The company’s second product is BP-C2, wh...

Latest news

February 2011. Meabco A/S has concluded its Far Eastern dose escalating clinical trials of its anti-cancer drug BP-C1 in patients with advanced metastatic breast cancer at three leading university hospitals in Taiwan, Indonesia and Thailand. The preliminary results are very encouraging....

March 2011. Meabco A/S Meabco A/S - intensifies its ongoing development of its Radio-protective agent BP-C2 that can be used effectively not only as prophylactic but also for post-radiation treatment purposes.